Skip to content

Playtika Holding Corp. PLTK Issuance of vested restricted stock units

Issuance of vested restricted stock units at other companies

ARD
Ardent Health PartnersARDT
-$1.01M+4.4%
UFP Technologies logo
UFP TechnologiesUFPT
-$3.57M+8.8%
Zymeworks logo
ZymeworksZYME
$0
Playtika Holding Corp. logo
Playtika Holding Corp.PLTK
$0
FTI Consulting logo
FTI ConsultingFCN
-$2.37M+67.2%
DJT
Trump Media & Technology GroupDJT
$0

Other financials

Income statement

See full
Revenue$744.7M+5.5%
Gross profit$552.5M+8.6%
Operating income-$49.6M-173%
Net income-$57.5M-288%
EPS (diluted)-$0.15-287%

Balance sheet

See full
Cash & equivalents$779.2M+79.2%
Total debt$2.5B0.0%
Total equity-$463.1M-295%
Total assets$3.7B+3.1%

Cash flow

See full
Operating cash flow$22.8M+21.3%
CapEx$5.7M-45.2%
Free cash flow$17.1M+104%

Valuation

See full
Market cap$1.46B-45.7%
Enterprise value$3.21B-30.6%
P/S0.5×-0.5×

Profitability

See full
Gross margin73%+0.4pp
Operating margin-4.4%-18.3pp
Net margin-10.5%
FCF margin19.3%+2.4pp

Returns & leverage

See full
Return on equity68.2%
Debt / equity-5.4×
Current ratio1.2×-0.6×

Where this comes from

Reported directly by Playtika Holding Corp. in its filing.

Tagged under the XBRL concept us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures.

The official record: Playtika Holding Corp.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Playtika Holding Corp.'s issuance of vested restricted stock units.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Playtika Holding Corp.'s issuance of vested restricted stock units?
Playtika Holding Corp. (PLTK) reported issuance of vested restricted stock units of $0 in Q1 2026.
What does issuance of vested restricted stock units mean?
The total value of restricted stock units that have vested and been issued to employees or directors during the reporting period. This metric represents a form of non-cash compensation and indicates the extent of equity-based incentive programs. It is critical for analyzing shareholder dilution and compensation expenses.